Sudeep Pharma Limited IPO

₹14,825 Min Investment

Issue Opening Date
November 21, 2025
Issue Closing Date
November 25, 2025
Price Band
Rs 563 to Rs 593 per share
Lot Size
25 Shares
Sudeep Pharma Limited IPO ClosedOpen

₹14,825

Min. investment
Invest Now

1. Company Information

Incorporated in 1989, Sudeep Pharma Limited is a manufacturer of pharmaceutical excipients, food-grade minerals, and specialty nutrition ingredients serving over 100 countries. The company operates six manufacturing facilities with a combined production capacity of 50,000 MT, specializing in minerals such as calcium, iron, magnesium, zinc, potassium, and sodium The company supplies more than 200 products to a diverse customer base across pharma, food, and nutrition sectors The company has strong R&D capabilities with in-house labs and pilot-scale facilities focused on mineral salts and excipients. Product Portfolio: Pharmaceutical, Food and Nutrition Business Specialty Ingredients Business Triturates

2. Competitive Strengths

Market leadership with a diversified product portfolio in a high barrier industry.
Distinguished global customer base with long-standing relationships with key customers.
Well-equipped and regulatory compliant Manufacturing Facilities
Strong research and development capabilities

3.Sudeep Pharma Limited IPO  Registrar

MUFG Intime India Pvt.Ltd.

+91-22-4918 6270
sudeeppharma.ipo@in.mpms.mufg.com
https://linkintime.co.in/Initial_Offer/public-issues.html

Sudeep Pharma Limited Details

Issue Opening Date November 21, 2025
Issue Closing Date November 25, 2025
Face Value Rs 1 per share
Price Rs 563 to Rs 593 per share
Lot Size 25 Shares
Sale Type Fresh Capital-cum-Offer for Sale
Total Issue Size 1,50,92,750 shares (aggregating up to Rs 895.00 Cr)
Fresh Issue 16,02,024 shares (aggregating up to Rs 95.00 Cr)
Offer for Sale 1,34,90,726 shares of Rs 1 (aggregating up to Rs 800.00 Cr)
Issue Type Bookbuilding IPO
Listing At BSE, NSE

Sudeep Pharma Limited Timeline (Tentative Schedule)

Event Tentative Date
Opening Date Fri, Nov 21, 2025
Closing Date Tue, Nov 25, 2025
Tentative Allotment Wed, Nov 26, 2025
Initiation of Refunds Thu, Nov 27, 2025
Credit of Shares to Demat Thu, Nov 27, 2025
Listing Date Fri, Nov 28, 2025
Cut-off time for UPI mandate confirmation 5 PM on Tue, Nov 25, 2025

Sudeep Pharma Limited Financial Information (Restated)

Period Ended
Total Assets
Total Revenue
Profit After Tax
EBITDA
Net Worth
Reserves and Surplus
Total Borrowing
31-Mar-25
717.17
511.33
138.69
199.28
497.53
481.11
135.25
31-Mar-24
513.87
465.38
133.15
187.76
359.07
354.59
75.03
31-Mar-23
420.11
438.26
62.32
98.64
226.29
221.88
82.26
Amount in Rs. Crore

Prospectus Document

Official Red Herring Prospectus (RHP)

For detailed company and issue information

SEBI Registration No: NSE Cash: INB231219636 | SEBI Registration No: NSE Derivative: INF231219636 | SEBI Registration No: BSE Cash: INB011219632 | SEBI Registration No: MCX-SX: INE261219636 | SEBI Registration No: NSE Currency: INE231219636 | SEBI Registration No: USE: INE271219631 | SEBI Registration No: CDSL: IN-DP-CDSL-3242005 | NCDEX Membership No: 00635 | MCX Membership No: 28850 | NSEL Membership No: 10650 | RBI Registration No: NBFC: N-14.03215 | IRDA Registration Number : CB-066/03 | AMFI Registration No : ARN -0032| SEBI Registration No: Merchant Banker: INM000007508

* Mutual fund investments are subject to market risks. Please read the scheme information and other related documents carefully before investing.